Home / Inspections / 1038535

FDA Inspection 1038535 — Dimitri Karmpaliotis, MD

Dimitri Karmpaliotis, MD — FEI 3014133509

The FDA completed an inspection of Dimitri Karmpaliotis, MD on Jan 9, 2018 in New York, NY. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Devices.

Inspection Details

Classification
No Action Indicated (NAI)
End Date
Jan 9, 2018
Fiscal Year
2018
Product Type
Devices
Project Area
Bioresearch Monitoring
Location
New York, NY (United States)

Additional Details

Clinical Investigator (CI)

Facility

FDA data resources

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.